Palo Alto Investors LP

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1306923 PALO ALTO, CA

Position in IOVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$22,286,966

+$2,858,441 QoQ

Shares Held

6,349,563

-10.8% QoQ

Ownership

1.42%

of shares outstanding

% of Portfolio

3.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Palo Alto Investors LP holds $530,756,561 across 38 Biotechnology names. IOVA ranks #9 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	415,269	$67,904,786
2	ACAD	Acadia Pharmaceuticals Inc	2,872,695	$63,946,190
3	PTCT	Ptc Therapeutics, Inc.	921,607	$62,789,084
4	BMRN	Biomarin Pharmaceutical Inc	685,182	$38,705,931
5	MIRM	Mirum Pharmaceuticals, Inc.	325,175	$30,039,666
6	DYN	Dyne Therapeutics, Inc.	1,652,972	$29,968,382
7	IRON	Disc Medicine, Inc.	401,719	$25,685,912
8	ANAB	Anaptysbio, Inc	638,161	$23,594,918

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$22,286,966	6,349,563	-10.8%	Shares	Sole	2026-05-15
2025-12-31	$19,428,525	7,116,676	-6.6%	Shares	Sole	2026-02-17
2025-09-30	$16,531,346	7,618,132	+122.1%	Shares	Sole	2025-11-14
2025-06-30	$5,898,445	3,429,329	+6.8%	Shares	Sole	2025-08-14
2025-03-31	$10,693,675	3,211,314	+5.6%	Shares	Sole	2025-05-15
2024-12-31	$22,508,469	3,041,685	0.0%	Shares	Sole	2025-02-14
2024-09-30	$28,561,422	3,041,685	+43.7%	Shares	Sole	2024-11-14
2024-06-30	$16,973,552	2,116,403	+0.2%	Shares	Sole	2024-08-14
2024-03-31	$31,311,859	2,112,811	+0.3%	Shares	Sole	2024-05-15
2023-12-31	$17,128,218	2,106,792	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.